Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease-results of the Immune Metabolic Associations in Psoriatic Arthritis study.
第一作者:
Lyn D,Ferguson
第一单位:
Institute of Cardiovascular and Medical Sciences, University of Glasgow.
作者:
医学主题词
成年人(Adult);关节炎, 牛皮癣(Arthritis, Psoriatic);体脂分布(Body Fat Distribution);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);磷酸二酯酶4抑制剂(Phosphodiesterase 4 Inhibitors);前瞻性研究(Prospective Studies);银屑病(Psoriasis);沙立度胺(Thalidomide);体重减轻(Weight Loss)
DOI
10.1093/rheumatology/keab474
PMID
34097014
发布时间
2022-03-14
- 浏览0
Rheumatology (Oxford, England)
1026-1034页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



